Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT03016156
Eligibility Criteria:
Inclusion Criteria - Stratum I:
* Patient has been diagnosed with congenital or infantile cataracts, congenital glaucoma, or retinoblastoma, and is scheduled for a visit with an ophthalmologist at St. Jude Children's Research Hospital or University of Tennessee Hamilton Eye Institute.
* Patient with retinoblastoma is newly diagnosed, or has received \< 2 cycles of chemoreductive therapy, and has not undergone enucleation.
* Patient with cataracts or glaucoma has not received any prior therapy.
Inclusion Criteria - Stratum II:
* Patient without prior diagnosis has been referred for ophthalmological evaluation, including leukocoria or other conditions.
Inclusion Criteria - Stratum III:
* Patient with retinoblastoma undergoing ocular salvage treatment.
Exclusion Criteria
* Prior treatment for cataracts or glaucoma
* Inability or unwillingness of research participant or legal guardian to consent.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
7 Years
Study:
NCT03016156
Study Brief:
Protocol Section:
NCT03016156